Motus GI Holdings, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Pure-Vu® System
    • Overview
    • Inpatient Colonoscopy
    • High Medical Need Outpatient Colonoscopy
    • Publications
  • Healthcare Professionals
    • Clinical Benefits
    • Clinical Studies
    • Become a Pure-Vu® System Provider
  • News & Media
    • Press Releases
    • Multimedia
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Results
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us

Nasdaq Bell Ringing Ceremony
Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Results
    • Overview
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Governance
    • Board of Directors
    • Contact the Board
    • Board Committees
    • Governance Documents
  • Investor Tools  
    • Email Alerts
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Apr 6, 2021

Motus GI Submits 510(k) Application to FDA for the Pure-Vu System for Upper GI Endoscopy

Mar 16, 2021

Motus GI Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update

Mar 15, 2021

Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center

Mar 8, 2021

Motus GI to Present Pure-Vu GEN2 System at the Centers for Medicare and Medicaid Services ICD-10 Reimbursement Code Committee Meeting

Mar 2, 2021

Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16

Mar 1, 2021

Motus GI to Participate in Two Upcoming Investor Conferences in March 2021

Feb 24, 2021

Motus GI Announces U.S. Patent for the Pure-Vu® System’s Connectivity with Nearly All Commercial Colonoscopes to Provide Improved Visualization During Colonoscopy

Jan 27, 2021

Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million

Jan 15, 2021

Motus GI Announces European Clearance of Enhanced Pure-Vu® GEN2 System to Harmonize with U.S. Configuration

Jan 11, 2021

Motus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Universal Method to Mount on the End of Most Commercial Colonoscopes

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
© 2021 Motus GI Holdings, Inc. All Rights Reserved.
Privacy Policy General Terms & Conditions Disclaimer Sitemap